6-K - InflaRx N.V. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

InflaRx N.V. announced its 2026 Annual General Meeting to be held on April 23, 2026, featuring shareholder votes on director re-appointments, board share issuance and buyback authorities, articles of association amendments, and adoption of a new Long-term Incentive Plan.

Key Takeaways

1Re-appointment of co-founders Niels Riedemann (CEO) and Renfeng Guo (CSO) through 2030 confirms continuity in executive leadership and scientific strategy.

2Board seeks extension of authority to acquire up to 10% of issued ordinary shares at ≤110% of 5-day average Nasdaq closing price — enabling flexible capital management.

3Proposal to amend articles of association to increase authorized share capital supports future equity-based financing or compensation needs.

4Approval of LTIP 2026 introduces a new long-term incentive plan, aligning executive and employee interests with shareholder value creation.

5No dividend policy change: company reaffirms it has never paid cash dividends and does not anticipate doing so in the foreseeable future.

Current Report Details

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Securities Issuance